Ensysce Biosciences Inc (ENSC): Next-Year EPS Estimate 94.44%
As of 2026-06-04, Ensysce Biosciences Inc (ENSC) has a next-year EPS growth estimate of 94.44%.
On 2026-05-19, analyst consensus for ENSC's next-year EPS growth shifted from 93.87% to 94.44% — a positive change of 0.57 percentage points. The revised estimate has been sustained across 13 subsequent trading sessions. Current-year growth is projected at 50.25%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 94.44%
- EPS growth this year
- 50.25%
- EPS next quarter (est)
- -$0.50
- Last price
- $0.30
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 94.44% | 50.25% | -$0.50 | $0.30 |
| 2026-06-03 | 94.44% | 50.25% | -$0.50 | $0.26 |
| 2026-06-02 | 94.44% | 50.25% | -$0.50 | $0.26 |
| 2026-06-01 | 94.44% | 50.25% | -$0.50 | $0.28 |
| 2026-05-31 | 94.44% | 50.25% | -$0.50 | $0.28 |
| 2026-05-28 | 94.44% | 50.25% | -$0.52 | $0.30 |
| 2026-05-27 | 94.44% | 50.25% | -$0.52 | $0.30 |
| 2026-05-26 | 94.44% | 50.25% | -$0.52 | $0.31 |
| 2026-05-25 | 94.44% | 50.25% | -$0.52 | $0.32 |
| 2026-05-24 | 94.44% | 50.25% | -$0.52 | $0.32 |
| 2026-05-21 | 94.44% | 50.25% | -$0.52 | $0.32 |
| 2026-05-20 | 94.44% | 50.25% | -$0.52 | $0.31 |
| 2026-05-19 | 94.44% | 50.25% | -$0.52 | $0.30 |
| 2026-03-20 | 93.87% | N/A | N/A | $0.58 |
| 2026-03-19 | 93.87% | N/A | N/A | $0.57 |
| 2026-03-18 | 93.87% | N/A | N/A | $0.63 |
| 2026-03-17 | 93.87% | N/A | N/A | $0.47 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Ensysce Biosciences Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Ensysce Biosciences Inc (ENSC) has a next-year EPS growth estimate of 94.44%, based on analyst consensus.
When was the latest EPS estimate revision for ENSC?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 93.87% to 94.44%.
What sector and industry does Ensysce Biosciences Inc belong to?▾
Ensysce Biosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ENSC appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ensysce Biosciences Inc (ENSC) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports